| Community Epidemiology Work Group (CEWG)*** In June 2000, CEWG members reported that heroin indicators showed mixed 
          trends. Mortality figures were mixed, with deaths increasing notably 
          in Austin, Detroit, Minneapolis/St. Paul, and Phoenix, and declining 
          in Miami, Philadelphia, St. Louis, San Diego, and Seattle. Emergency 
          room admissions were also mixed, with 10 cities showing decreases (significant 
          in San Francisco and Washington, D.C.), and 10 showing increases (particularly 
          Baltimore and Miami). Heroin continues to account for a substantial 
          proportion of treatment admissions in some CEWG areas (e.g., 47.8 percent 
          in Baltimore, 43 percent in New York City, and 32 percent in Detroit). 
          Heroin injection characterizes a large proportion of primary heroin 
          treatment admissions (e.g., 90 percent in Texas). During the second 
          quarter of 1999, the highest purity levels were found in Philadelphia 
          (71 percent); New York (63.6 percent); Boston (61.4 percent); Newark 
          (60.7 percent); Atlanta (57.8 percent); and San Diego (57.6 percent). 
          Purity levels in other CEWG areas ranged from 11.8 percent in Dallas 
          to 46.7 percent in Detroit. Injecting is on an upward trend among younger 
          users in Baltimore, Boston, Minneapolis/St. Paul, Newark, New York City, 
          and Seattle. In Boston, Chicago, Denver, Miami, and Washington, D.C., 
          snorting seems to be increasing and is often the starting route for 
          new users. National Household Survey on Drug Abuse (NHSDA)ư The 1999 NHSDA study reports the use of illicit drugs by those people 
          age 12 and older. The lifetime prevalence (at least one use in a persons 
          lifetime) for heroin for those people age 12 and older was 1.4 percent. By age category, 0.4 percent were in the 12-17 range; 1.8 percent were 
          18-25; and 1.4 percent were users age 26 and older.  
         
   "Lifetime" refers to use at least once during a respondent's 
          lifetime. "Past year" refers to an individual's drug use at least once 
          during the year preceding their response to the survey. "Past month" 
          refers to an individual's drug use at least once during the month preceding 
          their response to the survey.  * State Resources and Services Related to Alcohol and Other Drug Problems 
          for Fiscal Year 1995: An Analysis of State Alcohol and Drug Abuse Profile 
          Data, written by the National Association of State Alcohol and Drug 
          Abuse Directors (NASADAD), July 1997, is available from NASADAD at 202-293-0090. 
         ** The MTF survey is conducted by the University of Michigan's Institute 
          for Social Research and is funded by National Institute on Drug Abuse, 
          National Institutes of Health; it has tracked 12th graders' illicit 
          drug use and related attitudes since 1975. In 1991, 8th and 10th graders 
          were added to the study. For the 1998 study, 49,866 students were surveyed 
          from a representative sample of 422 public and private schools nationwide. 
          Copies of the latest survey are available from the National Clearinghouse 
          for Alcohol and Drug Information at 1-800-729-6686.  *** CEWG is 
          a NIDA-sponsored network of researchers from 20 major U.S. metropolitan 
          areas and selected foreign countries who meet semiannually to discuss 
          the current epidemiology of drug abuse. CEWG's most recent report is 
          Epidemiologic Trends in Drug Abuse, Volume I, June 2000.  ư NHSDA is an annual survey conducted by the Substance Abuse and Mental 
          Health Services administration. Copies of the latest survey are available 
          from the National Clearinghouse for Alcohol and Drug Information at 
          1-800-729-6686.  
 This page has been accessed 43064 times 
          since 11/5/99.  
         
             
             
              |  | U.S. Department of Health and Human Services 
                · National Institutes of Health. Send comments and questions to 
                NIDA Infofax, P.O. Box 30652, Bethesda, MD. 20824-0652. This material 
                may be used or reproduced withouth permission from NIDA. Citation 
                of the source is appreciated. |  For additional information about NIDA send e-mail to Information@lists.nida.nih.gov
 |